BR112021023519A2 - Mediadores de silenciamento genético - Google Patents
Mediadores de silenciamento genéticoInfo
- Publication number
- BR112021023519A2 BR112021023519A2 BR112021023519A BR112021023519A BR112021023519A2 BR 112021023519 A2 BR112021023519 A2 BR 112021023519A2 BR 112021023519 A BR112021023519 A BR 112021023519A BR 112021023519 A BR112021023519 A BR 112021023519A BR 112021023519 A2 BR112021023519 A2 BR 112021023519A2
- Authority
- BR
- Brazil
- Prior art keywords
- present
- genetic silencing
- silencing mediators
- trna
- mediators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/30—Detection of binding sites or motifs
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/113—Antisense targeting other non-coding nucleic acids, e.g. antagomirs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/531—Stem-loop; Hairpin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Plant Pathology (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Data Mining & Analysis (AREA)
- Hospice & Palliative Care (AREA)
Abstract
mediadores de silenciamento genético. a presente invenção refere-se a um método para inibir a expressão de um gene em um sistema biológico. o método da presente invenção compreende introduzir um polinucleotídeo derivado de trna no sistema biológico. o polinucleotídeo derivado de trna da presente invenção compreende uma sequência que seja complementar a uma região intrônica do gene cuja expressão deve ser inibida.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1907380.8A GB201907380D0 (en) | 2019-05-24 | 2019-05-24 | Mediators of gene silencing |
PCT/GB2020/051257 WO2020240162A1 (en) | 2019-05-24 | 2020-05-22 | Mediators of gene silencing |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112021023519A2 true BR112021023519A2 (pt) | 2022-01-25 |
Family
ID=66867557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112021023519A BR112021023519A2 (pt) | 2019-05-24 | 2020-05-22 | Mediadores de silenciamento genético |
Country Status (9)
Country | Link |
---|---|
US (1) | US20220220476A1 (pt) |
EP (1) | EP3976784A1 (pt) |
JP (1) | JP2022533236A (pt) |
CN (1) | CN113924366A (pt) |
AU (1) | AU2020284492A1 (pt) |
BR (1) | BR112021023519A2 (pt) |
CA (1) | CA3140501A1 (pt) |
GB (1) | GB201907380D0 (pt) |
WO (1) | WO2020240162A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB202018570D0 (en) * | 2020-11-25 | 2021-01-06 | Cancer Research Tech Ltd | Mediators of gene silencing |
CN114836538B (zh) * | 2022-04-14 | 2023-04-07 | 南昌大学第一附属医院 | 生物标志物在hbv相关肝癌诊断及预后中的应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005086896A2 (en) * | 2004-03-10 | 2005-09-22 | Ulrich Thomann | Delivery vectors for short interfering rna, micro-rna and antisense rna |
WO2012006551A2 (en) * | 2010-07-08 | 2012-01-12 | The Brigham And Women's Hospital, Inc. | Neuroprotective molecules and methods of treating neurological disorders and inducing stress granules |
WO2012018881A2 (en) * | 2010-08-03 | 2012-02-09 | Alnylam Pharmaceuticals, Inc. | Methods and compositions for the regulation of rna |
US20160024575A1 (en) * | 2013-05-02 | 2016-01-28 | The Regents Of The University Of California | Circulating small noncoding rna markers |
WO2016069641A1 (en) * | 2014-10-28 | 2016-05-06 | Thomas Jefferson University | COMPOSITIONS AND METHODS OF USING TRANSFER RNAS (tRNAs) |
WO2018009547A1 (en) * | 2016-07-05 | 2018-01-11 | The Usa, As Represented By The Secretary, Dept. Of Health And Human Services | Diagnosing col6-related disorders and methods for treating same |
WO2018204412A1 (en) * | 2017-05-01 | 2018-11-08 | Thomas Jefferson University | Systems-level analysis of tcga cancers reveals disease trna fragmentation patterns and associations with messenger rnas and repeat |
-
2019
- 2019-05-24 GB GBGB1907380.8A patent/GB201907380D0/en not_active Ceased
-
2020
- 2020-05-22 BR BR112021023519A patent/BR112021023519A2/pt unknown
- 2020-05-22 CA CA3140501A patent/CA3140501A1/en active Pending
- 2020-05-22 EP EP20730096.3A patent/EP3976784A1/en active Pending
- 2020-05-22 US US17/609,691 patent/US20220220476A1/en active Pending
- 2020-05-22 AU AU2020284492A patent/AU2020284492A1/en active Pending
- 2020-05-22 CN CN202080038339.4A patent/CN113924366A/zh active Pending
- 2020-05-22 JP JP2021569167A patent/JP2022533236A/ja active Pending
- 2020-05-22 WO PCT/GB2020/051257 patent/WO2020240162A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20220220476A1 (en) | 2022-07-14 |
AU2020284492A1 (en) | 2021-12-23 |
JP2022533236A (ja) | 2022-07-21 |
CA3140501A1 (en) | 2020-12-03 |
CN113924366A (zh) | 2022-01-11 |
WO2020240162A1 (en) | 2020-12-03 |
EP3976784A1 (en) | 2022-04-06 |
GB201907380D0 (en) | 2019-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112016019267B8 (pt) | Método para construir um perfil de dna, biblioteca de ácido nucléico, método para construir uma biblioteca de ácido nucléico, pluralidade de iniciadores e kit | |
Yu et al. | mi R‐34c Enhances Mouse Spermatogonial Stem Cells Differentiation by Targeting Nanos2 | |
Butler et al. | Regulatory RNAs and control of epigenetic mechanisms: expectations for cognition and cognitive dysfunction | |
BR112018003625A2 (pt) | composições e métodos de aprimoramento da especificidade em engenharia genômica usando endonucleases guiadas por rna | |
Bogliotti et al. | Mechanisms of histone H3 lysine 27 trimethylation remodeling during early mammalian development | |
BR112018007177A2 (pt) | edição de genoma multiplexado | |
BR112021023519A2 (pt) | Mediadores de silenciamento genético | |
BR112017012765A2 (pt) | ?métodos para editar uma sequência de nucleotídeos, célula e linhagem de e. coli e método para produzir uma célula de e. coli? | |
BR112015009589A2 (pt) | processos de produção de um animal de produção não humano, animal de produção geneticamente modificado não humano, organismo in vitro não humano escolhido do grupo que consiste em uma célula ou um animal blastocisto, o organismo in vitro, processo de produção de uma célula de animal de produção geneticamente modificado não humano, animal de produção não humano e método de produção de um animal de produção geneticamente modificado não humano | |
EP3656873A3 (en) | Polynucleotide enrichment and amplification using argonaute systems | |
Kremer et al. | Interplay between TETs and microRNAs in the adult brain for memory formation | |
BR112012013875B8 (pt) | método in vitro para reprogramar células somáticas humanas ou de outros mamíferos para células tronco pluripotentes induzidas (células ips ou ipscs) e composição | |
Lin et al. | Characterization of microRNA expression profiles and the discovery of novel microRNAs involved in cancer during human embryonic development | |
Itou et al. | Induction of DNA methylation by artificial piRNA production in male germ cells | |
Warner et al. | Micro RNA expression profiling of the developing murine upper lip | |
BR112015021210B8 (pt) | Método para reduzir a expressão de um ácido nucleico alvo em uma planta e ácido nucleico recombinante | |
Meng et al. | MicroRNA profiling analysis revealed different cellular senescence mechanisms in human mesenchymal stem cells derived from different origin | |
Zhou et al. | Roles of miRNAs in microcystin-LR-induced Sertoli cell toxicity | |
MX2021007001A (es) | Moleculas inhibidoras de acido nucleico de cadena doble que contienen un tribucle. | |
BR112017027311A2 (pt) | microorganismos de propagação & métodos relacionados & sistemas | |
Qian et al. | The full-length transcripts and promoter analysis of intergenic microRNAs in Drosophila melanogaster | |
CL2021001488A1 (es) | Transposasa de piggybac mutada | |
BR112022008468A2 (pt) | Método para modificação direcionada de uma sequência de genoma de planta | |
Svoboda | Why mouse oocytes and early embryos ignore miRNAs? | |
Sun et al. | The role of let-7b in the inhibition of hepatic stellate cell activation by rSjP40 |